Man­u­fac­tur­ing roundup: Astel­las to sell Dutch fa­cil­i­ty to Del­pharm; Au­ri­gene in­vest­ing $40M in­to In­dia man­u­fac­tur­ing fa­cil­i­ty

Astel­las Phar­ma is sell­ing its man­u­fac­tur­ing plant in Mep­pel, the Nether­lands, to con­tract man­u­fac­tur­er Del­pharm.

Astel­las said last week it’s trans­fer­ring the fa­cil­i­ty to Del­pharm as part of a wider shift for the phar­ma’s tech­nol­o­gy and man­u­fac­tur­ing busi­ness. As part of the deal, for which fi­nan­cial de­tails were not dis­closed, Del­pharm plans to con­tin­ue to pro­duce the prod­ucts that are made in the Mep­pel plant for Astel­las. The em­ploy­ees at the site will al­so trans­fer to Del­pharm as well. The deal is ex­pect­ed to close by the end of the year.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.